AKTX
Akari Therapeutics, Plc
There isn't enough reported data to score AKTX yet.
AKTX Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
AKTX's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
AKTX PE Valuation
AKTX has no meaningful PE right now: it lost money over the past year.
AKTX Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| -- | |
| -- | |
| Limited | |
| High |
Analysts expect AKTX's losses to grow, with revenue holding steady.
AKTX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.00 | $0.00 |
| Q2 2026 | $0.00 | $0.00 |
| Q1 2026 | $0.00 | $0.00 |
| Q4 2025 | $0.00 | $0.00 |
AKTX lost $0.00 per share over the past year, a bigger loss than the year before.
AKTX Quarterly Revenue
AKTX's revenue is shrinking: $0 last quarter.
AKTX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$4.2M | -$2.1M |
| Q2 2026 | -$3.1M | +$147K |
| Q1 2026 | -$2.5M | -$338K |
| Q4 2025 | -$3M | -$917K |
| Q3 2025 | -$2.1M | -$631K |
| Q2 2025 | -$3.3M | +$1.6M |
| Q1 2025 | -$2.2M | +$1.9M |
| Q4 2024 | -$2.1M | +$2.3M |
AKTX has burned cash in almost every quarter: −$13M over the past year, against −$10M the year before.
AKTX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +86% | +123B shares |
| 1 year | +16797% | +264B shares |
AKTX has 266B diluted shares, up 16797% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2023 | — |
| Q3 2023 | $1,000 |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
AKTX Net Leverage
AKTX's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
AKTX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.6 | Neutral |
| Stochastic | 15.3 | Oversold |
AKTX's weekly RSI is 40 (neutral) and its Stochastic is 15 (oversold).
AKTX PE vs Healthcare Sector
AKTX has no meaningful PE right now: it lost money over the past year.
AKTX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $8.22 | 21% below |
| 20 week MA | $9.13 | 29% below |
| 50 week MA | $9.49 | 31% below |
| 100 week MA | $25.5 | 74% below |
| 200 week MA | $81.8 | 92% below |
AKTX is in a downtrend: it's below all five of its weekly moving averages, and 92% below its 200-week average.
AKTX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1,376.0 | $1,520.0 | +10% |
| 2021 | $1,520.0 | $1,232.0 | -19% |
| 2022 | $1,232.0 | $360.0 | -71% |
| 2023 | $360.0 | $124.8 | -65% |
| 2024 | $124.8 | $38.7 | -69% |
| 2025 | $38.7 | $10.6 | -73% |
| 2026 YTD | $10.6 | $6.51 | -39% |
AKTX has finished five years in a row lower, and it's down 39% so far in 2026.